Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


ALKERMES reported $277.61M in Trade Debtors for its fiscal quarter ending in March of 2023.

Trade Debtors Change
Acadia Pharmaceuticals ACAD:US USD 70.25M 7.17M
Acorda Therapeutics ACOR:US USD 9.19M 4.68M
Amgen AMGN:US USD 5.74B 173M
Biogen BIIB:US USD 2.03B 108.2M
BioMarin Pharmaceutical BMRN:US USD 597.91M 136.6M
Coherus Biosciences CHRS:US USD 101.46M 8.51M
Eli Lilly LLY:US USD 9.02B 463.2M
Gilead Sciences GILD:US USD 4.16B 615M
Heron Therapeutics HRTX:US USD 51.45M 601K
Horizon Pharma HZNP:US USD 624.7M 51.65M
Intra Cellular Therapies ITCI:US USD 81.54M 6.36M
Ionis Pharmaceuticals IONS:US USD 13.91M 11.62M
J&J JNJ:US USD 16.35B 190M
Marinus Pharmaceuticals MRNS:US USD 11.69M 5.34M
Nektar Therapeutics NKTR:US USD 2.99M 2.99M
Neurocrine Biosciences NBIX:US USD 391.6M 41.6M
Otsuka Holdings 4578:JP JPY 390.04B 36.34B
Regeneron Pharmaceuticals REGN:US USD 5.12B 210.1M
Revance Therapeutics RVNC:US USD 15.37M 4.03M
Vertex Pharmaceuticals VRTX:US USD 1.55B 105.6M